Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Digibind for Bipolar Disorder
NCT00550576Phase 2Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Oct 2007
- Primary completion
- Feb 2009
- Modality
- Antibody Fragments, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of digoxin immune fab in bipolar disorder (BD), sponsored by Rambam Health Care Campus. Started Oct 2007; status: completed.
02
Drugs
digoxin immune fab
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00550576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00550576.